Warby Parker WRBY
NYSE WRBY
$27.44 -0.02 (-0.07%)
At close: Aug 21, 2026 · 4:00 PM EDT

Warby Parker (WRBY) Cash from Investing Activities (2020 - 2026)

Warby Parker's (WRBY) quarterly Cash from Investing Activities came in at -$16.1 million in Q1 2026, little changed YoY from -$16.1 million in Q1 2025, and down 6.73% on a QoQ basis from -$15.1 million in Q4 2025.

Warby Parker (WRBY) Cash from Investing Activities (2020 - 2026) Analysis & Trends

Warby Parker (WRBY) has 7 years of Cash from Investing Activities data on file, last reported at -$16.1 million in Q1 2026.

  • Quarterly Cash from Investing Activities changed 0.09% year-over-year to -$16.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$67.0 million (down 1.96% YoY) and the FY2025 annual result came in at -$67.0 million, down 1.54% from the prior year.
  • Cash from Investing Activities slipped to -$16.1 million in Q1 2026, from -$15.1 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of -$12.2 million in Q2 2023 to a low of -$19.5 million in Q3 2025.
  • A 5-year average of -$15.5 million and a median of -$16.1 million in 2022 frame the typical range for Cash from Investing Activities.
  • Annual changes were most pronounced in 2022 — Cash from Investing Activities tumbled 84.9% — and 2023, when it climbed 22.88%.
  • Tracing WRBY's Cash from Investing Activities over 5 years: stood at -$14.2 million in 2022, then rose by 4.52% to -$13.6 million in 2023, then plunged by 30.56% to -$17.7 million in 2024, then advanced by 14.68% to -$15.1 million in 2025, then decreased by 6.73% to -$16.1 million in 2026.
  • The last three Cash from Investing Activities figures came in at -$16.1 million (Q1 2026), -$15.1 million (Q4 2025), and -$19.5 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Intuitive Surgical 134.13 Bn 128.91 Bn 1.96 Bn -26.60 Mn
2 Becton Dickinson 52.76 Bn 51.90 Bn 2.32 Bn -241.00 Mn
3 Alcon 35.81 Bn 34.46 Bn 1.68 Bn -222.00 Mn
4 Resmed 33.72 Bn 32.25 Bn 861.22 Mn -383.65 Mn
5 Medline 29.38 Bn 26.70 Bn 2.22 Bn -461.00 Mn
6 West Pharmaceutical Services 25.00 Bn 24.57 Bn 329.20 Mn -43.20 Mn
7 Solventum 15.46 Bn 15.06 Bn 1.29 Bn -87.00 Mn
8 Cooper Companies 14.88 Bn 14.74 Bn 735.40 Mn -90.00 Mn
9 Baxter International 13.58 Bn 11.43 Bn 1.03 Bn -117.00 Mn
10 Warby Parker 3.41 Bn 3.12 Bn 136.46 Mn -22.86 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 -22.86 Mn
Jun 30, 2026 -22.86 Mn
Mar 31, 2026 -16.14 Mn
Mar 31, 2026 -16.14 Mn
Dec 31, 2025 -15.12 Mn
Dec 31, 2025 -15.12 Mn
Sep 30, 2025 -19.49 Mn
Sep 30, 2025 -19.49 Mn
Jun 30, 2025 -16.29 Mn
Jun 30, 2025 -16.29 Mn
Mar 31, 2025 -16.15 Mn
Mar 31, 2025 -16.15 Mn
Dec 31, 2024 -17.72 Mn
Dec 31, 2024 -17.72 Mn
Sep 30, 2024 -14.22 Mn
Sep 30, 2024 -14.22 Mn
Jun 30, 2024 -17.65 Mn
Jun 30, 2024 -17.65 Mn
Mar 31, 2024 -16.44 Mn
Mar 31, 2024 -16.44 Mn